Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 5/20 | 0.38 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | PPARA | Q07869 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | GCGR | P47871 | 1/20 | 0.31 |
| ▸ | TYMP | P19971 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL285375 | 0.89 | GCGR (0.40) | TLR8TLR7GCGR | |
| SCHEMBL15255830 | 0.86 | TLR8 (0.34) | TLR8TLR7TDP1SMN1; SMN2TP53 | |
| SCHEMBL285798 | 0.82 | LMNA (0.33) | TLR8TLR7TDP1L3MBTL1SMN1; SMN2 | |
| SCHEMBL109295 | 0.82 | GCGR (0.35) | TLR8TLR7L3MBTL1SMN1; SMN2TP53 | |
| SCHEMBL285480 | 0.82 | TLR8 (0.36) | TLR8TLR7TP53GAA | |
| SCHEMBL5734668 | 0.82 | PPARA (0.33) | TLR8TLR7KMT2APPARAMEN1 | |
| SCHEMBL18647926 | 0.81 | TLR8 (0.42) | TLR8TLR7TDP1SMN1; SMN2TP53 | |
| SCHEMBL17514350 | 0.80 | MLYCD (0.40) | TLR8TLR7KMT2APPARAMEN1 | |
| SCHEMBL18898429 | 0.79 | TLR8 (0.41) | TLR8TLR7KMT2ATDP1KCNH2 | |
| SCHEMBL22459185 | 0.79 | TLR8 (0.41) | TLR8TLR7KMT2ATDP1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2223568-A | — | — | None | — | — | JP | disclosed |
| EP-0725777-A1 | PROCESS FOR PREPARING 3,4-DIARYL-5-ISOXAZOLYL ACETIC ACID DERIVATIVES | F. JOH. KWIZDA GESELLSCHAFT M.B.H. (AT) | 1996-08-14 | — | — | EP | disclosed |
| EP-0464218-B1 | PROCESS FOR PRODUCING ISOXAZOLE DERIVATIVE | TAIHO PHARMACEUTICAL CO LTD (JP) | 1995-08-23 | — | — | EP | disclosed |
| WO-1995011888-A1 | PROCESS FOR PREPARING 3,4-DIARYL-5-ISOXAZOLYL ACETIC ACID DERIVATIVES | F. JOH. KWIZDA GESELLSCHAFT M.B.H. (AT) | 1995-05-04 | — | — | WO | disclosed |
| EP-0454871-B1 | ALPHA, BETA-UNSATURATED KETONE AND KETOXIME DERIVATIVE | TAIHO PHARMACEUTICAL CO LTD (JP) | 1995-04-12 | — | — | EP | disclosed |
| US-5310926-A | Process for producing isoxazole derivatives | TAIHO PHARMACEUTICAL CO., LIMITED (JP) | 1994-05-10 | — | — | US | disclosed |
| US-5142091-A | α, β-unsaturated ketones and ketoxime derivatives | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1992-08-25 | — | — | US | disclosed |
| EP-0464218-A1 | PROCESS FOR PRODUCING ISOXAZOLE DERIVATIVE | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1992-01-08 | — | — | EP | disclosed |
| EP-0454871-A1 | ALPHA, BETA-UNSATURATED KETONE AND KETOXIME DERIVATIVE | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) | 1991-11-06 | — | — | EP | disclosed |
| JP-H02223568-A | ISOXAZOLE DERIVATIVE AND PRODUCTION THEREOF | TAIHO YAKUHIN KOGYO KK | 1990-09-05 | — | — | JP | disclosed |
| EP-0026928-B1 | 3,4-DIARYLISOXAZOL-5-ACETIC ACID COMPOUNDS, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICALS CONTAINING THE SAME | CDC Life Sciences Inc. (CA) | 1984-01-25 | — | — | EP | disclosed |